Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma - PubMed (original) (raw)
Multicenter Study
doi: 10.1016/j.juro.2010.03.030. Epub 2010 May 15.
Shahrokh F Shariat, Michael P Herman, Casey K Ng, Douglas S Scherr, Benjamin Scoll, Robert G Uzzo, Mark Wille, Scott E Eggener, John D Terrell, Steven M Lucas, Yair Lotan, Stephen A Boorjian, Jay D Raman
Affiliations
- PMID: 20478585
- DOI: 10.1016/j.juro.2010.03.030
Multicenter Study
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma
James C Brien et al. J Urol. 2010 Jul.
Abstract
Purpose: We evaluated the value of hydronephrosis, ureteroscopic biopsy grade and urinary cytology to predict advanced upper tract urothelial carcinoma.
Materials and methods: We reviewed the charts of 469 patients with upper tract urothelial carcinoma treated with radical nephroureterectomy or distal ureterectomy. Complete data on hydronephrosis (present vs absent), ureteroscopic grade (high vs low) and urinary cytology (positive vs negative) were available in 172 patients. The outcome was muscle invasive (pT2-pT4) or nonorgan confined (pT3 or greater, or lymph node metastasis) upper tract urothelial carcinoma.
Results: Of the patients 92 (54%) had hydronephrosis, 74 (43%) had high grade disease on ureteroscopic biopsy and 137 (80%) had positive cytology. On univariate analysis hydronephrosis (p <0.001), high ureteroscopic grade (p <0.001) and positive cytology (p = 0.03) were associated with muscle invasive and nonorgan confined disease. On multivariate analysis adjusting for tumor site, gender and age hydronephrosis and high ureteroscopic grade were associated with muscle invasive carcinoma (HR 12.0 and 4.5, respectively, each p <0.001) but cytology was not (HR 2.3, p = 0.17). However, all 3 variables were independently associated with nonorgan confined disease (HR 5.1, p <0.001; HR 3.9, p <0.001; and HR 3.1, p = 0.035, respectively). Combining these 3 tests incrementally improved the prediction of upper tract urothelial carcinoma stage. Abnormality of all 3 tests had 89% and 73% positive predictive value for muscle invasive and nonorgan confined upper tract urothelial carcinoma, respectively, but when all tests were normal, the negative predictive value was 100%.
Conclusions: Preoperative evaluation for hydronephrosis, ureteroscopic grade and cytology can identify patients at risk for advanced upper tract urothelial carcinoma. Such knowledge may impact surgery choice and extent as well as the need for perioperative chemotherapy regimens.
Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
- Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?
Sakano S, Inamoto T, Inoue R, Matsumoto H, Nagao K, Yamamoto Y, Azuma H, Matsuyama H. Sakano S, et al. Jpn J Clin Oncol. 2015 Oct;45(10):968-72. doi: 10.1093/jjco/hyv114. Epub 2015 Jul 30. Jpn J Clin Oncol. 2015. PMID: 26232447 - Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma.
Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V, Silver H, Clinton TN, Krabbe LM, Woldu SL, Singla N, Bagrodia A, Margulis V, Huang WC, Bjurlin MA, Shah O, Anderson CB. Margolin EJ, et al. J Urol. 2018 Jun;199(6):1440-1445. doi: 10.1016/j.juro.2018.02.002. Epub 2018 Feb 7. J Urol. 2018. PMID: 29427584 - Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
Ito Y, Kikuchi E, Tanaka N, Miyajima A, Mikami S, Jinzaki M, Oya M. Ito Y, et al. J Urol. 2011 May;185(5):1621-6. doi: 10.1016/j.juro.2010.12.035. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419429 - Ureteroscopic management of upper urinary tract transitional cell carcinoma.
Johnson GB, Grasso M. Johnson GB, et al. Curr Opin Urol. 2005 Mar;15(2):89-93. doi: 10.1097/01.mou.0000160622.13366.a1. Curr Opin Urol. 2005. PMID: 15725931 Review. - Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA. Cutress ML, et al. BJU Int. 2012 Sep;110(5):614-28. doi: 10.1111/j.1464-410X.2012.11068.x. Epub 2012 Apr 3. BJU Int. 2012. PMID: 22471401 Review.
Cited by
- Radiomics-Based Computed Tomography Urogram Approach for the Prediction of Survival and Recurrence in Upper Urinary Tract Urothelial Carcinoma.
Alqahtani A, Bhattacharjee S, Almopti A, Li C, Nabi G. Alqahtani A, et al. Cancers (Basel). 2024 Sep 10;16(18):3119. doi: 10.3390/cancers16183119. Cancers (Basel). 2024. PMID: 39335090 Free PMC article. - Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.
Gravestock P, Cullum D, Somani B, Veeratterapillay R. Gravestock P, et al. Asian J Urol. 2024 Apr;11(2):242-252. doi: 10.1016/j.ajur.2022.08.003. Epub 2022 Sep 23. Asian J Urol. 2024. PMID: 38680592 Free PMC article. Review. - Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma.
Milojevic B, Janicic A, Grozdic Milojevic I, Grubor N, Bumbasirevic U, Radovanovic M, Radisavcevic D, Jovanovic D, Sretenovic M, Durutovic O, Sipetic Grujicic S. Milojevic B, et al. Ann Surg Oncol. 2024 Apr;31(4):2538-2544. doi: 10.1245/s10434-023-14844-y. Epub 2024 Jan 8. Ann Surg Oncol. 2024. PMID: 38190056 - Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.
Bitaraf M, Ghafoori Yazdi M, Amini E. Bitaraf M, et al. Cancers (Basel). 2023 Oct 14;15(20):4987. doi: 10.3390/cancers15204987. Cancers (Basel). 2023. PMID: 37894354 Free PMC article. Review. - Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma.
Zganjar AJ, Thiel DD, Lyon TD. Zganjar AJ, et al. Transl Androl Urol. 2023 Sep 30;12(9):1456-1468. doi: 10.21037/tau-23-45. Epub 2023 Aug 4. Transl Androl Urol. 2023. PMID: 37814699 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical